Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
7m agoreAlpha (NASDAQ: AIRE) Announces 1-for-25 Reverse Stock Split to be Effective on April 30, 2026
8m agoEdible Garden Named Among Top 25 Greenhouse Produce Growers in the U.S. in 2026
8m agoRising uncertainty reshapes reputational risk, but organisations hold firm on controls, says Willis
8m agoRedCloud Unveils Specialist AI Agents Trained on $6.9 Billion FMCG Trade Dataset — Targeted to Improve Thousands of Commercial Decisions Daily
9m agoFood Metal Cans Markets, 2025-2030 with Ball Corp, Crown Holdings, Silgan, Ardagh Group, and CCL Industries Dominating
Agios Pharm logo

Agios Pharm

About

Agios Pharm (NASDAQ:AGIO) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 6 2026
Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET
Mar 31 2026
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA
Mar 2 2026
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in the United Arab Emirates
Feb 12 2026
Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Jan 26 2026
Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET

Financials

Revenue
$54.03 M
Market Cap
$2.06 B
EPS
-7.12

Community Chat

Ask AI

6ix6ixAIEvents